Home > Field of Cooperation > Health Research > Innovative Bacteriophage-Antibiotic Therapeutics Targeting the Extremely-Drug Resistant Superbugs
Innovative Bacteriophage-Antibiotic Therapeutics Targeting the Extremely-Drug Resistant Superbugs |
| Principal Investigator / Affiliation | Tony Velkov (Associate Professor) / Head of the Anti-infective Pharmacology Unit, Monash University  Australia |
|---|---|
Andrea Lay Hoon Kwa (Deputy Director and Pharmacy) / Singapore General Hospital  Singapore |
|
Gauri Rao (Associate Professor) / Director of the Quantitative Disease and Drug Modeling Center, University of Southern California  USA |
|
| Year Adopted | 2024 |
| Research Period | 3 years |
| General Description of the Research Project | Over population and antibiotic overuse has led to widespread infectious diseases caused by antimicrobial resistant (AMR) bacteria. Serendipitously, these unfortunate events have also led to the co-evolution of super-phages in sewage that kill these super-bugs. Our project aims to break the AMR vicious cycle by harnessing the bacterial killing power of these super-phages and combine them with new-generation antibiotics to develop novel therapies against these deadly infections. |
| Photo Gallery | |
| Reports | |
| Links |
Researchers
| Principal Investigator / Country of Research Team | 
Tony Velkov Australia
Andrea Lay Hoon Kwa Republic of Singapore
Gauri Rao the United States |
|---|